Forecast came true

Cara Therapeutics, Inc. (CARA) Will Bounce Back
10 july

Cara Therapeutics, Inc. (CARA) is in free-fall after reporting mixed results. Yet the stock will bottom and bounce back as speculators bottom-fish.

Fundamentals are weak. The 1mg, 2.5mg, and 5mg dose results failed to demonstrate joint pain reduction.

$CARA, CARA THERAPEUTICS Inc / H1

CARA will bottom at $10 a share. Agree or disagree?

Login via StockTwits, FB, TWTR to vote now. 'Like' this post.


Answered:
4 people

Cara Therapeutics, Inc. (CARA) Will Bounce Back

Agreed
4 people
Disagreed
0 people

Forecast came true

CARA +10%